Odyssey Health (ODYY) Profit After Tax Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Profit After Tax Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.04% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 108.33% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 592.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 592.83% |
| Jan 31, 2026 | -1,536.16% |
| Oct 31, 2025 | 52.55% |
| Jul 31, 2025 | 98.02% |
| Apr 30, 2025 | 70.11% |
| Jan 31, 2025 | -101.66% |
| Oct 31, 2024 | -89.38% |
| Jul 31, 2024 | -1,465.03% |
| Apr 30, 2024 | 34.40% |
| Jan 31, 2024 | 894.24% |
| Oct 31, 2023 | 74.97% |
| Jul 31, 2023 | 59.42% |
| Apr 30, 2023 | 58.57% |
| Jan 31, 2023 | 1.24% |
| Oct 31, 2022 | -30.57% |
| Jul 31, 2022 | 30.85% |
| Apr 30, 2022 | 75.01% |
| Jan 31, 2022 | -94.72% |
| Oct 31, 2021 | -131.38% |
| Jul 31, 2021 | -117.76% |